Invention Grant
US08841330B2 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
有权
ω-羧基芳基取代的二苯脲作为raf激酶抑制剂
- Patent Title: Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
- Patent Title (中): ω-羧基芳基取代的二苯脲作为raf激酶抑制剂
-
Application No.: US13368812Application Date: 2012-02-08
-
Publication No.: US08841330B2Publication Date: 2014-09-23
- Inventor: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood
- Applicant: Bernd Riedl , Jacques Dumas , Uday Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood
- Applicant Address: US NJ Whippany
- Assignee: Bayer Healthcare LLC
- Current Assignee: Bayer Healthcare LLC
- Current Assignee Address: US NJ Whippany
- Agency: Millen, White, Zelano & Branigan, P.C.
- Main IPC: A61K31/44
- IPC: A61K31/44
Abstract:
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
Public/Granted literature
- US20120142742A1 OMEGA-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS Public/Granted day:2012-06-07
Information query
